MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 207 filers reported holding MEDIVATION INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,727,000 | +29.8% | 111,560 | -1.0% | 0.01% | +50.0% |
| Q1 2016 | $5,181,000 | -36.6% | 112,670 | -33.3% | 0.00% | -42.9% |
| Q4 2015 | $8,171,000 | +12.3% | 169,022 | -1.3% | 0.01% | +16.7% |
| Q3 2015 | $7,275,000 | -90.1% | 171,166 | -73.5% | 0.01% | -90.2% |
| Q2 2015 | $73,831,000 | -4.4% | 646,508 | +8.0% | 0.06% | -3.2% |
| Q1 2015 | $77,240,000 | +960.3% | 598,438 | +718.3% | 0.06% | +950.0% |
| Q4 2014 | $7,285,000 | -13.7% | 73,132 | -14.3% | 0.01% | -14.3% |
| Q3 2014 | $8,438,000 | +14.6% | 85,348 | -10.6% | 0.01% | +16.7% |
| Q2 2014 | $7,362,000 | +19.9% | 95,508 | +0.1% | 0.01% | +20.0% |
| Q1 2014 | $6,141,000 | +32.4% | 95,409 | +31.3% | 0.01% | +25.0% |
| Q4 2013 | $4,637,000 | -67.6% | 72,651 | -69.5% | 0.00% | -71.4% |
| Q3 2013 | $14,295,000 | +301.2% | 238,485 | +229.3% | 0.01% | +250.0% |
| Q2 2013 | $3,563,000 | – | 72,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |